Cellular functions of mitogen-activated protein kinases and protein tyrosine phosphatases in ovarian granulosa cells

Mariko Tamura1, Yosimi Nakagawa, Hidehisa Shimizu

  • 1Gene Research Center, University of Tsukuba, Ibaraki 305-8572, Japan.

Insights

Mitogen-activated protein kinase (MAPK) activities and protein tyrosine phosphatases (PTPs) are linked to granulosa cell survival and apoptosis. Understanding these pathways is crucial for comprehending follicular fate.

Area of Science:

  • Reproductive Biology
  • Cellular Signaling
  • Endocrinology

Background:

  • Follicular growth and atresia are regulated by endocrine and paracrine factors impacting granulosa cell survival and apoptosis.
  • The intracellular molecular mechanisms mediating these effects are not well understood.
  • Protein tyrosine kinases (PTKs) are known to be involved in granulosa cell survival and proliferation.

Purpose of the Study:

  • To investigate the correlation between mitogen-activated protein kinase (MAPK) activities and granulosa cell survival/apoptosis.
  • To elucidate the cellular functions of protein tyrosine phosphatases (PTPs) in granulosa cells.
  • To provide insights into the molecular mechanisms controlling follicular fate.

Main Methods:

  • Analysis of mitogen-activated protein kinase (MAPK) activities.
  • Assessment of protein tyrosine phosphatase (PTP) functions in granulosa cells.
  • Correlation studies linking signaling pathways to cell fate.

Main Results:

  • Mitogen-activated protein kinase (MAPK) activities are correlated with granulosa cell survival and apoptosis.
  • Protein tyrosine phosphatases (PTPs) play significant cellular roles in granulosa cells.
  • This study presents novel findings on PTPs in the ovary.

Conclusions:

  • MAPK and PTP signaling pathways are key regulators of granulosa cell fate.
  • Understanding these intracellular events is essential for comprehending follicular development and atresia.
  • This research lays the groundwork for future studies on ovarian molecular mechanisms.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Amplifying Signals via Second Messengers01:15

Amplifying Signals via Second Messengers

Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...